Ironwood Pharma (IRWD) Tops Q1 EPS by 6c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $53.58 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• First Industrial Realty (FR) Tops Q1 EPS by 21c
• Alcoa (AA) Misses Q1 EPS by 19c
• Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24